Insider Trading26 Jun 2026, 03:50 pm
Senores Pharma Closes Trading Window for Insider Trading Rules
AI Summary
Senores Pharmaceuticals Limited has announced the closure of its trading window for directors, promoters, designated persons, and their immediate relatives. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The window will be shut from July 01, 2026, until 48 hours after the declaration of the unaudited financial results for the quarter ending June 30, 2026. This measure is to prevent potential insider trading activities during the period leading up to and immediately following the financial results announcement. The exact date of the board meeting to approve these results will be communicated separately.
Key Highlights
- Trading window closed from July 01, 2026.
- Closure is due to upcoming financial results announcement.
- Applies to directors, promoters, and designated persons.
- Aims to comply with SEBI insider trading regulations.
- Duration is until 48 hours post-results declaration.
Price Impact
More from SENORES